{"DataElement":{"publicId":"7339573","version":"1","preferredName":"Lipid Measurement Assessment Performed Type","preferredDefinition":"A description of the lipid measurement assessment performed type.","longName":"7346765v1.0:7339571v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7346765","version":"1","preferredName":"Lipid Measurement Assessment Performed","preferredDefinition":"A quantitative measurement of the amount of lipids (cholesterol, lipoproteins, and triglycerides) present in a sample._The final result of a determination of the value, significance, or extent of._Executed and carried through to completion.","longName":"7346763v1.0:2241241v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"7346763","version":"1","preferredName":"Lipid Measurement Assessment","preferredDefinition":"A quantitative measurement of the amount of lipids (cholesterol, lipoproteins, and triglycerides) present in a sample.:The final result of a determination of the value, significance, or extent of.","longName":"C74949:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipid Measurement","conceptCode":"C74949","definition":"A quantitative measurement of the amount of lipids (cholesterol, lipoproteins, and triglycerides) present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9518AE9-37A5-693A-E053-4EBD850ABBF6","latestVersionIndicator":"Yes","beginDate":"2020-06-30","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-30","modifiedBy":"ONEDATA","dateModified":"2020-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9518AE9-37B3-693A-E053-4EBD850ABBF6","latestVersionIndicator":"Yes","beginDate":"2020-06-30","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-30","modifiedBy":"MALUMK","dateModified":"2020-07-30","changeDescription":"Released. 07/30/2020 KMM; Released. 07/30/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7339571","version":"1","preferredName":"Lipid Assessment Type","preferredDefinition":"A class of hydrocarbon-containing organic compounds. Lipids are insoluble in water but soluble in nonpolar solvents and play important roles in living organisms: these roles include functioning as energy storage molecules, serving as structural components of cell membranes, and constituting important signaling molecules. Lipids can be subdivided into 2 groups: fatty acids and glycerides._The final result of a determination of the value, significance, or extent of._Something distinguishable as an identifiable class based on common qualities.","longName":"7339571v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High-density lipoprotein (HDL)","valueDescription":"High Density Lipoprotein","ValueMeaning":{"publicId":"2580607","version":"1","preferredName":"High Density Lipoprotein","longName":"2580607","preferredDefinition":"High density lipoproteins are the smallest and densest lipoproteins, and contain a high proportion of protein. They are synthesized in the liver as empty proteins and they pick up cholesterol and increase in size as they circulate through the bloodstream.  Because HDL can remove cholesterol from the arteries, and transport it back to the liver for excretion, they are seen as \"good\" lipoproteins. (from Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Density Lipoprotein","conceptCode":"C25186","definition":"The smallest and densest lipoproteins, containing a high proportion of protein. They are synthesized in the liver as empty proteins and they pick up cholesterol and increase in size as they circulate through the bloodstream.  Because HDL can remove cholesterol from the arteries, and transport it back to the liver for excretion, they are seen as \"good\" lipoproteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-07EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-23","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A861E40B-E46D-2A79-E053-4EBD850A3BF9","beginDate":"2020-06-18","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-18","modifiedBy":"ONEDATA","dateModified":"2020-06-18","deletedIndicator":"No"},{"value":"Low-density lipoprotein (LDL)","valueDescription":"Low Density Lipoprotein","ValueMeaning":{"publicId":"2580606","version":"1","preferredName":"Low Density Lipoprotein","longName":"2580606","preferredDefinition":"Low-density lipoprotein (LDL) is a lipoprotein that carries cholesterol around the body, for use by various cells.  LDL transports cholesterol to the arteries and increased levels are associated with atherosclerosis, and thus myocardial infarctions and strokes. This is why cholesterol inside LDL lipoproteins is called bad cholesterol. (from Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Density Lipoprotein","conceptCode":"C25187","definition":"A lipoprotein that carries cholesterol around the body, for use by various cells.  LDL transports cholesterol to the arteries and increased levels are associated with atherosclerosis, and thus myocardial infarctions and strokes. This is why cholesterol inside LDL lipoproteins is called bad cholesterol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-07EB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-23","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A861E40B-E495-2A79-E053-4EBD850A3BF9","beginDate":"2020-06-18","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-18","modifiedBy":"ONEDATA","dateModified":"2020-06-18","deletedIndicator":"No"},{"value":"Cholesterol","valueDescription":"Cholesterol","ValueMeaning":{"publicId":"7339572","version":"1","preferredName":"Cholesterol","longName":"7339572","preferredDefinition":"An animal sterol found in the body tissues (and blood plasma) of vertebrates. It can be found in large concentrations within the liver, spinal cord, and brain. Cholesterol is an important component of the membranes of cells, providing stability. It is the major precursor for the synthesis of vitamin D, of the various steroid hormones, including cortisol, cortisone, and aldosterone in the adrenal glands, and of the sex hormones progesterone, estrogen, and testosterone.  Cholesterol also has an important role for the brain synapses as well as in the immune system.  In conditions featuring elevated low density lipoproteins (LDL), cholesterol often forms plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholesterol","conceptCode":"C369","definition":"An animal sterol found in the body tissues (and blood plasma) of vertebrates. It can be found in large concentrations within the liver, spinal cord, and brain. Cholesterol is an important component of the membranes of cells, providing stability. It is the major precursor for the synthesis of vitamin D, of the various steroid hormones, including cortisol, cortisone, and aldosterone in the adrenal glands, and of the sex hormones progesterone, estrogen, and testosterone.  Cholesterol also has an important role for the brain synapses as well as in the immune system.  In conditions featuring elevated low density lipoproteins (LDL), cholesterol often forms plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A861E40B-E49F-2A79-E053-4EBD850A3BF9","latestVersionIndicator":"Yes","beginDate":"2020-06-18","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-18","modifiedBy":"COLBERTM","dateModified":"2023-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A861E40B-E4B8-2A79-E053-4EBD850A3BF9","beginDate":"2020-06-18","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-18","modifiedBy":"ONEDATA","dateModified":"2020-06-18","deletedIndicator":"No"},{"value":"Very low-density lipoprotein (VLDL)","valueDescription":"Very Low Density Lipoprotein","ValueMeaning":{"publicId":"7342424","version":"1","preferredName":"Very Low Density Lipoprotein","longName":"7342424","preferredDefinition":"The lipoprotein fraction in plasma that primarily transports triglycerides synthesized in the liver to peripheral tissues where they may be utilized to generate energy in muscle or stored as reserves in adipose. As the triglycerides are hydrolyzed from their very low density lipoprotein (VLDL) carriers, the VLDL remnants (intermediate density lipoproteins, IDLs) may be further metabolized into low density lipoproteins (LDLs) which may ultimately promote atherogenesis. Alternatively, VLDL remnants may accept cholesterol esters transferred from high density lipoproteins (HDLs) and then be recycled to the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Very Low Density Lipoprotein","conceptCode":"C173032","definition":"The lipoprotein fraction in plasma that primarily transports triglycerides synthesized in the liver to peripheral tissues where they may be utilized to generate energy in muscle or stored as reserves in adipose. As the triglycerides are hydrolyzed from their very low density lipoprotein (VLDL) carriers, the VLDL remnants (intermediate density lipoproteins, IDLs) may be further metabolized into low density lipoproteins (LDLs) which may ultimately promote atherogenesis. Alternatively, VLDL remnants may accept cholesterol esters transferred from high density lipoproteins (HDLs) and then be recycled to the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8D6A321-BD7D-45C8-E053-4EBD850A22FD","latestVersionIndicator":"Yes","beginDate":"2020-06-24","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-24","modifiedBy":"ONEDATA","dateModified":"2020-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9C6C6E1-36D1-5FD0-E053-4EBD850AF325","beginDate":"2020-06-18","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-06","modifiedBy":"ONEDATA","dateModified":"2020-07-06","deletedIndicator":"No"},{"value":"Triglyceride","valueDescription":"Triglycerides","ValueMeaning":{"publicId":"3379243","version":"1","preferredName":"Triglycerides","longName":"3379243","preferredDefinition":"Fats composed of three fatty acid chains linked to a glycerol molecule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Triglycerides","conceptCode":"C906","definition":"Fats composed of three fatty acid chains linked to a glycerol molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B91A08CE-C305-784E-E040-BB89AD435DD1","latestVersionIndicator":"Yes","beginDate":"2012-02-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-16","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEAF2146-7F21-73A9-E053-4EBD850A645C","beginDate":"2021-03-29","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-29","modifiedBy":"ONEDATA","dateModified":"2021-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7339570","version":"1","preferredName":"Lipid Assessment Type","preferredDefinition":"A class of hydrocarbon-containing organic compounds. Lipids are insoluble in water but soluble in nonpolar solvents and play important roles in living organisms: these roles include functioning as energy storage molecules, serving as structural components of cell membranes, and constituting important signaling molecules. Lipids can be subdivided into 2 groups: fatty acids and glycerides.:The final result of a determination of the value, significance, or extent of.:Something distinguishable as an identifiable class based on common qualities.","longName":"C616:C25217:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipid","conceptCode":"C616","definition":"A class of hydrocarbon-containing organic compounds. Lipids are insoluble in water but soluble in nonpolar solvents and play important roles in living organisms: these roles include functioning as energy storage molecules, serving as structural components of cell membranes, and constituting important signaling molecules. Lipids can be subdivided into 2 groups: fatty acids and glycerides.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A861E40B-E43C-2A79-E053-4EBD850A3BF9","latestVersionIndicator":"Yes","beginDate":"2020-06-18","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-18","modifiedBy":"ONEDATA","dateModified":"2020-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A861E40B-E44D-2A79-E053-4EBD850A3BF9","latestVersionIndicator":"Yes","beginDate":"2020-06-18","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-18","modifiedBy":"MALUMK","dateModified":"2021-03-29","changeDescription":"Released. 07/30/2020 KMM. PVs added for 2100r7. 03/29/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"HPST_OOID_lipid_assessment_typ","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_VASC_lipid_assessment_typ","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the lipid measuremen","type":"Preferred Question Text","description":"What was the lipid measurement assessment performed type?","url":null,"context":"NHLBI"},{"name":"Specify which lipids were assessed","type":"Application Standard Question Text","description":"Specify which lipids were assessed","url":null,"context":"NHLBI"},{"name":"Specify which lipids were assessed","type":"Alternate Question Text","description":"Specify which lipids were assessed","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8622E93-E5C7-62FD-E053-4EBD850ABA7E","latestVersionIndicator":"Yes","beginDate":"2020-06-18","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":"Released 07/31/2020 KMM; System generated def displayed as alt def. 06/30/2020 KMM. ALT name added for 2100r7. 10/04/2021 KMM","administrativeNotes":"2023.8.24 Alt Name added per ticket request CADSR0002778. ak","unresolvedIssues":null,"deletedIndicator":"No"}}